Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.88 USD | -2.11% | -1.86% | -30.83% |
05-20 | Entero Therapeutics, Inc.(NasdaqCM:ENTO) added to NASDAQ Composite Index | CI |
05-16 | First Wave BioPharma, Inc.(NasdaqGM:ENTO) dropped from NASDAQ Composite Index | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.83% | 5.96M | |
+63.00% | 62.59B | |
-2.08% | 41.18B | |
+44.47% | 40.29B | |
-8.29% | 27.9B | |
+12.15% | 26.21B | |
-21.85% | 19.09B | |
+5.41% | 13.08B | |
+25.32% | 12.26B | |
+27.85% | 12.05B |
- Stock Market
- Equities
- ENTO Stock
- News Entero Therapeutics, Inc.
- AzurRx BioPharma : Reports Positive Topline Results in Study of Potential Drug for Severe Exocrine Pancreatic Insufficiency; Shares Rise Pre-Bell